“An authorized generic for kaléo’s naloxone HCl injection (Evzio®) will be available midyear in 2019, and will come with a list price of $178 per carton, each containing 2 auto-injectors. Offered through kaléo subsidiary IJ Therapeutics, the new authorized generic is the same formulation and design as the branded drug, but will have a different label.
Although Evzio is currently available for $0 out-of-pocket to eligible patients with commercial insurance, the lower list price of the authorized generic will offer a more affordable and cost-effective solution for Medicare Part D patients and plans.”
Read more at: https://www.pharmacytimes.com/news/generic-opioid-overdose-antidote-treatment-to-be-available-in-2019
Source: PharmacyTimes.com – December 13, 2018
